The Patent Finder
VC

Virginia Commonwealth University

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

127 patents currently held

29 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2 more records may belong here and await a decision; they are not counted.

The next term ends in Nov 2026. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
24
Ending by 2030
Nov 2026
Next term end
99
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank

Formerly held, still cited

Notable
Cited by 25 later US patents, top 10% of utility patents granted in 2021 in our data. Protection runs to 2039.
Ends Feb 2039 · High confidence
Also notable
The most cited patent in this portfolio, cited by 60 later US patents, top 10% of utility patents granted in 2016 in our data. Protection runs to 2029.
Ends Apr 2029 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 4 fees due Nov 23 to 30, 2026 · next Nov 23
  • 3 fees due Dec 6 to 13, 2026 · next Dec 6
  • 2 fees due Jan 4 to 9, 2027 · next Jan 4
  • 1 fee due Feb 28, 2027
    The maintenance fee for Sphingosine Kinase Type 1 Inhibitors and Uses Thereof (US 11,737,992) comes due Feb 28, 2027. Unpaid by Aug 30, 2027, it lapses early.
  • 1 fee due Mar 17, 2027
    The maintenance fee for Method for One-Step Synthesis, Cross-Linking and Drying of Aerogels (US 10,414,894) comes due Mar 17, 2027. Unpaid by Sep 17, 2027, it lapses early.
  • 3 fees due Apr 1 to 29, 2027 · next Apr 1
  • 1 fee due May 14, 2027
    The maintenance fee for Nitric Oxide-Releasing 3D-PRINTING Compositions and Uses Thereof (US 11,814,519) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
  • 2 fees due Aug 6 to 13, 2027 · next Aug 6
  • 4 fees due Sep 1 to 24, 2027 · next Sep 1
  • 1 fee due Oct 21, 2027
    The maintenance fee for Sphingosine Kinase Type 1 Inhibitors and Uses Thereof (US 10,624,863) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.
  • 1 fee due Nov 17, 2027
    The maintenance fee for Assessment and Prediction of Cardiovascular Status During Cardiac Arrest and the Post-Resuscitation Period Using Signal Processing and Machine Learning (US 9,339,241) comes due Nov 17, 2027. Unpaid by May 17, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 5 of the patents on this record were granted since Aug 20, 2026
  • 6 terms have ended since Aug 20, 2026

What they patent

The 5 largest of its 99 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 9,376,472Polyvalent Chimeric Ospc Vaccinogen and Diagnostic Antigen
In force
 · Low confidence
In forceLow confidence
US 10,751,494Prevention of Ventilator Associated Pneumonia (VAP)
In force
 · Medium confidence
In forceMedium confidence
US 7,668,357Method and System for Using Computed Tomography to Test Pulmonary Function
In force
 · High confidence
In forceHigh confidence
US 9,457,163Prevention of Ventilator Associated Pneumonia (VAP)
In force
 · High confidence
In forceHigh confidence
US 8,042,544Prevention of Ventilator Associated Pneumonia (VAP)
In force
 · High confidence
In forceHigh confidence
US 8,609,360Method for Diagnosing Acute Ischemic Events in Human Subjects
In force
 · High confidence
In forceHigh confidence
US 7,781,580Stilbene Derivatives as New Cancer Therapeutic Agents
In force
 · High confidence
In forceHigh confidence
US 8,591,921Induction of Tumor Hypoxia for Cancer Therapy
In force
 · High confidence
In forceHigh confidence
US 10,159,676Induction of Tumor Hypoxia for Cancer Therapy
In force (reinstated)
 · High confidence
In force (reinstated)High confidence
US 10,426,779Induction of Tumor Hypoxia for Cancer Therapy
In force
 · High confidence
In forceHigh confidence
10 of 127 patents shown.
Pro members see all 127.
Pro members: see all 127 patents
Also on record, not counted in the 127: 29 patents in force now held by others · 156 patents ended · 101 applications pending · 171 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited